Primary antituberculosis drug resistance and acquired rifampicin resistance in Gujarat, India

Tubercle. 1988 Mar;69(1):37-42. doi: 10.1016/0041-3879(88)90038-4.

Abstract

The prevalence of primary antituberculosis drug resistance in Gujarat, as studied between 1983 and 1986, was found to be significantly high, especially for isoniazid (13.9%) and streptomycin (7.4%). Primary rifampicin and pyrazinamide resistance were not detected in any strain. The prevalence of rifampicin resistance among treatment failure and relapse cases of pulmonary tuberculosis increased significantly from 2.8% in 1980 to 37.3% in 1986. In about 95% of the rifampicin resistant strains there was also resistance to isoniazid or streptomycin or both: resistance to isoniazid was detected in more than 90%.

MeSH terms

  • Antitubercular Agents / pharmacology*
  • Drug Resistance, Microbial
  • Humans
  • India
  • Isoniazid / pharmacology
  • Microbial Sensitivity Tests
  • Mycobacterium tuberculosis / drug effects*
  • Pyrazinamide / pharmacology
  • Rifampin / pharmacology*
  • Streptomycin / pharmacology
  • Tuberculosis, Pulmonary / microbiology

Substances

  • Antitubercular Agents
  • Pyrazinamide
  • Isoniazid
  • Rifampin
  • Streptomycin